Changes to Anaphore's senior management
This article was originally published in Scrip
Anaphore has appointed Dr Michael Haller senior vice-president of strategic partnerships and H Casey Logan senior vice-president of business development. Dr Haller will manage the company's R&D partnership with Mitsubishi Tanabe Pharma Corporation, and most recently served as vice-president of alliance management and portfolio development at Halozyme Therapeutics. Mr Logan previously led corporate development and strategic planning efforts at Anadys Pharmaceuticals.